Study of a novel indolylquinoline compound that induces apoptosis in human non-small cell lung cancer and hepatocellular carcinoma cells through p53 activation
博士 === 國立臺灣師範大學 === 生命科學系 === 104 === Lung cancer is the leading cause of cancer mortality worldwide. NSCLC accounts for about 75% to 80% of lung cancer cases. Chemotherapy adverse side effects and resistance to current anticancer agents have been the pressing problems in the success of lung cancer...
Main Authors: | Liu, Chun-Yen, 劉俊彥 |
---|---|
Other Authors: | Fang, Kang |
Format: | Others |
Language: | en_US |
Published: |
2016
|
Online Access: | http://ndltd.ncl.edu.tw/handle/26208319107833898957 |
Similar Items
-
一.A Novel Indolylquinoline Derivative Induced Apoptosis in Human Non-small Cell Lung Cancer Cells 二.
by: Pei-Tsen Wu, et al.
Published: (2014) -
Mechanisms of Teroxirone and Indolylquinoline Compound That Impair Growth in Cancer Stem-Like Cells of Human Non-Small-Cell-Lung-Cancer
by: Ni, Yu-Ling, et al.
Published: (2016) -
Role of cell apoptosis regulated by P53 in treatment of hepatocellular carcinoma
by: GAO Si, et al.
Published: (2017-07-01) -
T cells are depleted in HCV-induced hepatocellular carcinoma patients: possible role of apoptosis and p53
by: Esmat Gamal, et al.
Published: (2006-12-01) -
The role of p53 and PKC in TRAIL-induced apoptosis in non-small cell lung cancer cells
by: Chuan-Ming, et al.
Published: (2005)